GDI2-IN-1 (compound (+)-37), a GDP-dissociation inhibitor beta (GDI2) inhibitor, demonstrates potent inhibitory activity with an IC50 of 2.87 µM and a K D of 36 µM, and exhibits excellent in vivo antitumor efficacy in pancreatic xenograft models overexpr
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
